Marked hypofrontality in clozapine-responsive patients. (Record no. 17226079)

MARC details
000 -LEADER
fixed length control field 01428 a2200421 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515080337.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200710s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0176-3679
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1055/s-2007-984399
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Molina, V
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20071025
245 00 - TITLE STATEMENT
Title Marked hypofrontality in clozapine-responsive patients.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Pharmacopsychiatry
Date of publication, distribution, etc. Jul 2007
300 ## - PHYSICAL DESCRIPTION
Extent 157-62 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antipsychotic Agents
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Caudate Nucleus
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clozapine
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fluorodeoxyglucose F18
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Frontal Lobe
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Magnetic Resonance Imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Positron-Emission Tomography
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prefrontal Cortex
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Radiopharmaceuticals
General subdivision pharmacokinetics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Schizophrenia
General subdivision diagnostic imaging
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thalamus
General subdivision drug effects
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sanz, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sarramea, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Palomo, T
773 0# - HOST ITEM ENTRY
Title Pharmacopsychiatry
Related parts vol. 40
-- no. 4
-- p. 157-62
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1055/s-2007-984399">https://doi.org/10.1055/s-2007-984399</a>
Public note Available from publisher's website

No items available.